iShares Genomics Immunology and Healthcare ETF Stock Forecast, Price & News

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Frequently Asked Questions

What stocks does MarketBeat like better than iShares Genomics Immunology and Healthcare ETF?

Wall Street analysts have given iShares Genomics Immunology and Healthcare ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but iShares Genomics Immunology and Healthcare ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has iShares Genomics Immunology and Healthcare ETF's stock been impacted by Coronavirus (COVID-19)?

iShares Genomics Immunology and Healthcare ETF's stock was trading at $26.77 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, IDNA stock has increased by 99.9% and is now trading at $53.50.
View which stocks have been most impacted by COVID-19.

Is iShares Genomics Immunology and Healthcare ETF a good dividend stock?

iShares Genomics Immunology and Healthcare ETF pays an annual dividend of $0.09 per share and currently has a dividend yield of 0.16%.
View iShares Genomics Immunology and Healthcare ETF's dividend history.

What other stocks do shareholders of iShares Genomics Immunology and Healthcare ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Genomics Immunology and Healthcare ETF investors own include Pfizer (PFE), Gilead Sciences (GILD), Intel (INTC), AbbVie (ABBV), Inovio Pharmaceuticals (INO), Novavax (NVAX), Canadian Natural Resources (CNQ), QUALCOMM (QCOM), SPDR S&P Biotech ETF (XBI) and Bristol-Myers Squibb (BMY).

What is iShares Genomics Immunology and Healthcare ETF's stock symbol?

iShares Genomics Immunology and Healthcare ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IDNA."

Who are iShares Genomics Immunology and Healthcare ETF's major shareholders?

iShares Genomics Immunology and Healthcare ETF's stock is owned by a variety of institutional and retail investors. Top institutional investors include Wealthcare Advisory Partners LLC (1.68%), Baird Financial Group Inc. (0.72%), Sigma Planning Corp (0.09%), Flow Traders U.S. LLC (0.08%), Patriot Financial Group Insurance Agency LLC (0.08%) and Wealthcare Capital Management LLC (0.08%).

Which institutional investors are selling iShares Genomics Immunology and Healthcare ETF stock?

IDNA stock was sold by a variety of institutional investors in the last quarter, including Flow Traders U.S. LLC, and Sigma Planning Corp.

Which institutional investors are buying iShares Genomics Immunology and Healthcare ETF stock?

IDNA stock was purchased by a variety of institutional investors in the last quarter, including Wealthcare Advisory Partners LLC, Patriot Financial Group Insurance Agency LLC, Baird Financial Group Inc., and Wealthcare Capital Management LLC.

How do I buy shares of iShares Genomics Immunology and Healthcare ETF?

Shares of IDNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares Genomics Immunology and Healthcare ETF's stock price today?

One share of IDNA stock can currently be purchased for approximately $53.50.

How much money does iShares Genomics Immunology and Healthcare ETF make?

iShares Genomics Immunology and Healthcare ETF has a market capitalization of $369.15 million.